Functionalization Silver nanoparticles loaded with paclitaxel induced A549 cells apoptosis through ROS-Mediated signaling pathways.
Currently, paclitaxel (PTX) is one of the most important and effective anticancer drug for treatment of human cancer. Unfortunately it is limited by low solubility and severe adverse effects in clinical use. Silver nanoparticles (AgNPs) have been used to overcome tumors due to its excellent antimicrobial activity and free radical scavenging. Here, to overcome this limitation, this study was to demonstrate the anticancer properties of functionalized AgNPs with superior anticancer on ROS-mediated signaling pathway on A549 cells. PTX were capped with AgNPs (Ag@PTX) through physical adsorption, leading to the stable structure. The Ag@PTX nanoparticles were negatively charged with a zeta potential of about -17 mv and characterized around 2 nm with a narrow size distribution. Ag@PTX significantly decreased the cell viability of A549 and possessed selectivity between cancer and normal cells. Apoptosis in A549 cells by Ag@PTX was proved by sub-G1 cell population, nuclear condensation and DNA fragmentation. Furthermore, Ag@PTX induced apoptosis was found by activation of caspase-3 and dependent on ROS generation. The signaling pathways of p53 and AKT were activated by Ag@PTX to induce cell apoptosis. Finally, in a xenograft nude mice model, Ag@PTX suppressed the growth of tumors. Taken together, our findings suggest that Ag@PTX may be a candidate as a chemopreventive agent and could be a highly efficient way to achieve anticancer synergism for human cancers.